{"id":"https://openalex.org/W4399298331","doi":"https://doi.org/10.1158/1078-0432.c.7265768","title":"Data from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses","display_name":"Data from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses","publication_year":2024,"publication_date":"2024-06-03","ids":{"openalex":"https://openalex.org/W4399298331","doi":"https://doi.org/10.1158/1078-0432.c.7265768"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.7265768","doi":"https://doi.org/10.1158/1078-0432.c.7265768","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7265768","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.7265768","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035993804","display_name":"Anna Morena D\u2019Alise","orcid":"https://orcid.org/0000-0002-0763-6269","observed_orcids":["https://orcid.org/0000-0002-0763-6269"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Morena D'Alise","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0763-6269","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055345185","display_name":"Guido Leoni","orcid":"https://orcid.org/0000-0003-0502-1962","observed_orcids":["https://orcid.org/0000-0003-0502-1962"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guido Leoni","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0502-1962","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073524051","display_name":"Gabriella Cotugno","orcid":"https://orcid.org/0009-0009-5880-0215","observed_orcids":["https://orcid.org/0009-0009-5880-0215"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriella Cotugno","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-5880-0215","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013742096","display_name":"Loredana Siani","orcid":"https://orcid.org/0009-0000-6614-7396","observed_orcids":["https://orcid.org/0009-0000-6614-7396"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Loredana Siani","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-6614-7396","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087791595","display_name":"Rosa Vitale","orcid":"https://orcid.org/0009-0003-3160-4560","observed_orcids":["https://orcid.org/0009-0003-3160-4560"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosa Vitale","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-3160-4560","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082056132","display_name":"Valentino Ruzza","orcid":"https://orcid.org/0000-0002-0728-4240","observed_orcids":["https://orcid.org/0000-0002-0728-4240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valentino Ruzza","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0728-4240","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063622946","display_name":"Irene Garzia","orcid":"https://orcid.org/0009-0008-3001-2674","observed_orcids":["https://orcid.org/0009-0008-3001-2674"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irene Garzia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-3001-2674","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001192190","display_name":"Laura Antonucci","orcid":"https://orcid.org/0000-0001-8965-2432","observed_orcids":["https://orcid.org/0000-0001-8965-2432"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Antonucci","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8965-2432","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021066316","display_name":"Elisa Micarelli","orcid":"https://orcid.org/0000-0002-1180-0359","observed_orcids":["https://orcid.org/0000-0002-1180-0359"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisa Micarelli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1180-0359","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078516971","display_name":"Veronica Venafra","orcid":"https://orcid.org/0000-0003-3830-618X","observed_orcids":["https://orcid.org/0000-0003-3830-618X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veronica Venafra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3830-618X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085237357","display_name":"Sven Gogov","orcid":"https://orcid.org/0009-0002-1489-2778","observed_orcids":["https://orcid.org/0009-0002-1489-2778"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sven Gogov","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-1489-2778","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050948879","display_name":"Alessia Capone","orcid":"https://orcid.org/0000-0001-8639-356X","observed_orcids":["https://orcid.org/0000-0001-8639-356X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessia Capone","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8639-356X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048202615","display_name":"Sarah K. Runswick","orcid":"https://orcid.org/0009-0009-8895-3247","observed_orcids":["https://orcid.org/0009-0009-8895-3247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Runswick","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-8895-3247","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058642751","display_name":"Juan Mart\u00edn-Liberal","orcid":"https://orcid.org/0000-0003-2552-5172","observed_orcids":["https://orcid.org/0000-0003-2552-5172"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Martin\u2010Liberal","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2552-5172","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053069942","display_name":"Emiliano Calvo","orcid":"https://orcid.org/0000-0003-4921-829X","observed_orcids":["https://orcid.org/0000-0003-4921-829X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emiliano Calvo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4921-829X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006299989","display_name":"V\u00edctor Moreno","orcid":"https://orcid.org/0000-0001-6099-4236","observed_orcids":["https://orcid.org/0000-0001-6099-4236"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Moreno","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6099-4236","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053055306","display_name":"Stefan Nicholas Symeonides","orcid":"https://orcid.org/0000-0002-9892-9314","observed_orcids":["https://orcid.org/0000-0002-9892-9314"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan N. Symeonides","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9892-9314","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006663756","display_name":"Elisa Scarselli","orcid":"https://orcid.org/0000-0002-5393-6713","observed_orcids":["https://orcid.org/0000-0002-5393-6713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elisa Scarselli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5393-6713","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005521408","display_name":"Oliver Edgar Bechter","orcid":"https://orcid.org/0000-0003-0667-3284","observed_orcids":["https://orcid.org/0000-0003-0667-3284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Bechter","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0667-3284","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1160999983549118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/personalized-cancer-vaccines","display_name":"personalized cancer vaccines","score":0.8360000252723694},{"id":"https://openalex.org/keywords/viral-vector-vaccines","display_name":"viral vector vaccines","score":0.7910000085830688},{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.9110000133514404},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.906000018119812},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.7680000066757202},{"id":"https://openalex.org/keywords/modified-vaccinia-ankara","display_name":"modified vaccinia Ankara","score":0.9620000123977661},{"id":"https://openalex.org/keywords/t-cell-clonotypes","display_name":"T cell clonotypes","score":0.8149999976158142},{"id":"https://openalex.org/keywords/antitumor-t-cell-responses","display_name":"antitumor T-cell responses","score":0.7689999938011169},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.7110000252723694},{"id":"https://openalex.org/keywords/vaccine-immunogenicity","display_name":"vaccine immunogenicity","score":0.6959999799728394},{"id":"https://openalex.org/keywords/antigen-processing-machinery","display_name":"antigen processing machinery","score":0.847000002861023}],"concepts":[{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.5900089144706726},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.5101445317268372},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4915512502193451},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42797330021858215},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.413099080324173},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.40549540519714355},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3746137320995331},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33719950914382935},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3066452741622925},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.148917555809021},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09419256448745728},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.06619042158126831}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.7265768","doi":"https://doi.org/10.1158/1078-0432.c.7265768","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7265768","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.7265768.v1","doi":"https://doi.org/10.1158/1078-0432.c.7265768.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7265768.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.7265768","doi":"https://doi.org/10.1158/1078-0432.c.7265768","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7265768","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392986874","https://openalex.org/W4365511882","https://openalex.org/W4308395731","https://openalex.org/W4235049044","https://openalex.org/W2885419381","https://openalex.org/W4296706390","https://openalex.org/W4400272444","https://openalex.org/W4414312068","https://openalex.org/W2896379242","https://openalex.org/W2886663063"],"abstract_inverted_index":{"AbstractPurpose:":[0],"Personalized":[1],"vaccines":[2,93],"targeting":[3],"multiple":[4,139],"neoantigens":[5,140],"(nAgs)":[6],"are":[7],"a":[8,13,24,36,55,198,207,236],"promising":[9],"strategy":[10],"for":[11],"eliciting":[12],"diversified":[14],"antitumor":[15,203],"T-cell":[16,153],"response":[17],"to":[18,87,100,138,186,196,241],"overcome":[19],"tumor":[20,171],"heterogeneity.":[21],"NOUS-PEV":[22,60,185],"is":[23],"vector-based":[25],"personalized":[26],"vaccine,":[27],"expressing":[28],"60":[29],"nAgs":[30],"and":[31,73,85,115,144,149,188,201],"consists":[32],"of":[33,54,59,77,91,133,151,163,170,184,192,211,215,224,239],"priming":[34],"with":[35,46,63,68,108,131,165,220],"nonhuman":[37],"Great":[38],"Ape":[39],"Adenoviral":[40],"vector":[41],"(GAd20)":[42],"followed":[43],"by":[44,82,173],"boosts":[45],"Modified":[47],"Vaccinia":[48],"Ankara.":[49],"Here,":[50],"we":[51],"report":[52],"data":[53],"phase":[56],"Ib":[57],"trial":[58],"in":[61,65,123,159,232],"combination":[62],"pembrolizumab":[64],"treatment-na\u00efve":[66],"patients":[67,89,126,164],"metastatic":[69],"melanoma":[70],"(NCT04990479).":[71],"Patients":[72],"Methods:":[74],"The":[75,104],"feasibility":[76],"this":[78],"approach":[79],"was":[80,106,121,157],"demonstrated":[81,122],"producing,":[83],"releasing,":[84],"administering":[86],"6":[88],"11":[90],"12":[92],"within":[94],"8":[95],"weeks":[96],"from":[97],"biopsy":[98],"collection":[99],"GAd20":[101],"administration.":[102],"Results:":[103],"regimen":[105],"safe,":[107],"no":[109],"treatment-related":[110],"serious":[111],"adverse":[112],"events":[113],"observed":[114,158],"mild":[116],"vaccine-related":[117],"reactions.":[118],"Vaccine":[119],"immunogenicity":[120],"all":[124],"evaluable":[125],"receiving":[127],"the":[128,160,182,190,212,225,242],"prime/boost":[129],"regimen,":[130],"detection":[132],"robust":[134],"neoantigen-specific":[135,175],"immune":[136,204],"responses":[137],"comprising":[141],"both":[142],"CD4":[143],"CD8":[145],"T":[146,176,194,217],"cells.":[147,177],"Expansion":[148],"diversification":[150],"vaccine-induced":[152,174],"receptor":[154],"(TCR)":[155],"clonotypes":[156],"posttreatment":[161],"biopsies":[162,234],"clinical":[166],"response,":[167],"providing":[168],"evidence":[169],"infiltration":[172],"Conclusions:":[178],"These":[179],"findings":[180],"indicate":[181],"ability":[183],"amplify":[187],"broaden":[189],"repertoire":[191],"tumor-reactive":[193],"cells":[195,218],"empower":[197],"diverse,":[199],"potent,":[200],"durable":[202],"response.":[205],"Finally,":[206],"gene":[208],"signature":[209],"indicative":[210],"reduced":[213],"presence":[214],"activated":[216],"together":[219],"very":[221],"poor":[222],"expression":[223],"antigen-processing":[226],"machinery":[227],"genes":[228],"has":[229],"been":[230],"identified":[231],"pretreatment":[233],"as":[235],"potential":[237],"biomarker":[238],"resistance":[240],"treatment.":[243]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-06-04T00:00:00"}
